Advertisement
Research Article Free access | 10.1172/JCI109106
Find articles by Faber, O. in: JCI | PubMed | Google Scholar
Find articles by Hagen, C. in: JCI | PubMed | Google Scholar
Find articles by Binder, C. in: JCI | PubMed | Google Scholar
Find articles by Markussen, J. in: JCI | PubMed | Google Scholar
Find articles by Naithani, V. in: JCI | PubMed | Google Scholar
Find articles by Blix, P. in: JCI | PubMed | Google Scholar
Find articles by Kuzuya, H. in: JCI | PubMed | Google Scholar
Find articles by Horwitz, D. in: JCI | PubMed | Google Scholar
Find articles by Rubenstein, A. in: JCI | PubMed | Google Scholar
Find articles by Rossing, N. in: JCI | PubMed | Google Scholar
Published July 1, 1978 - More info
The metabolic clearance rate (MCR) of synthetic human connecting peptide (C-peptide) was measured with a single-dose injection technique in six normal and seven diabetic subjects and with a constant infusion technique in one normal subject. The MCR of C-peptide did not differ in normal subjects (4.4 ml/min per kg; range, 3.7-4.9) and in diabetic subjects (4.7 ml/min per kg; range, 3.7-5.8). Employment of both techniques in one subject gave similar MCR. The average half-life of C-peptide in plasma calculated from the last 1-h period of the single-dose injection studies was longer in the insulin-dependent diabetics (42.5 min; range, 39.4-48.5) than in the normal subjects (33.5 min; range, 24.9-45.3). These results indicate that the beta-cell secretory capacity of normal and insulin-dependent diabetic subjects can be compared by measuring the C-peptide concentration in peripheral venous plasma. The difference in the half-life of C-peptide in plasma between diabetics and normals suggests an altered kinetics of the disappearance of the peptide, while the overall metabolism, as expressed by the MCR, is similar.